Celgene (CELG) Analyst Notes after Receptos (RCPT) Acquisition: UBS analyst Matthew Roden – raises target Views deal as a positive as it adds a high-quality long-term growth asset that is…
Celgene (CELG) & Juno Therapeutics (JUNO) – Street Takeaways after CELG announces 10-year immuno-oncology deal and $1B investment in Juno Therapeutics : Leerink analyst Howard Liang – Very positive on…